{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:22:50Z","timestamp":1786378970552,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00228-021-03167-0","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:49:41Z","timestamp":1622767781000},"page":"1639-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin"],"prefix":"10.1007","volume":"77","author":[{"given":"Hiroyuki","family":"Tsujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-4690","authenticated-orcid":false,"given":"Yuki","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Koshiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kakimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/2050640613491254","volume":"1","author":"Y Ito","year":"2013","unstructured":"Ito Y, Sasaki M, Noguchi S et al (2013) Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury. United European Gastroenterol J 1:259\u2013264","journal-title":"United European Gastroenterol J"},{"key":"3167_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00535-009-0040-z","volume":"44","author":"H Endo","year":"2009","unstructured":"Endo H, Hosono K, Inamori M et al (2009) Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 44:544\u2013549","journal-title":"J Gastroenterol"},{"key":"3167_CR3","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3748\/wjg.v21.i17.5382","volume":"21","author":"C Mo","year":"2015","unstructured":"Mo C, Sun G, Lu ML et al (2015) Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries. World J Gastroenterol 21:5382\u20135392","journal-title":"World J Gastroenterol"},{"key":"3167_CR4","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.gie.2014.03.024","volume":"80","author":"H Endo","year":"2014","unstructured":"Endo H, Sakai E, Taniguchi L et al (2014) Risk factors for small-bowel mucosal breaks in chronic low-dose aspirin users: data from a prospective multicenter capsule endoscopy registry. Gastrointest Endosc 80:826\u2013834","journal-title":"Gastrointest Endosc"},{"key":"3167_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.mayocp.2014.07.015","volume":"89","author":"W Marlicz","year":"2014","unstructured":"Marlicz W, Loniewski I, Grimes DS et al (2014) Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine. Mayo Clin Proc 89:1699\u20131709","journal-title":"Mayo Clin Proc"},{"key":"3167_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1348-0421.1998.tb02294.x","volume":"42","author":"T Kinouchi","year":"1998","unstructured":"Kinouchi T, Kataoka K, Bing SR et al (1998) Culture supernatants of Lactobacillus acidophilus and Bifidobacterium adolescentis repress ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug by suppressing unbalanced growth of aerobic bacteria and lipid peroxidation. Microbiol Immunol 42:347\u2013355","journal-title":"Microbiol Immunol"},{"key":"3167_CR7","first-page":"237","volume":"54","author":"TH Kent","year":"1969","unstructured":"Kent TH, Cardelli RM, Stamler FW (1969) Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 54:237\u2013249","journal-title":"Am J Pathol"},{"key":"3167_CR8","doi-asserted-by":"crossref","unstructured":"Wallace JL, Syer S, Denou E et al (2011) Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 141:1314\u201322, 22 e1\u20135","DOI":"10.1053\/j.gastro.2011.06.075"},{"key":"3167_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/gut.48.2.163","volume":"48","author":"AZ Leite","year":"2001","unstructured":"Leite AZ, Sipahi AM, Dami\u00e3o AO et al (2001) Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut 48:163\u2013167","journal-title":"Gut"},{"key":"3167_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/gut.2007.125963","volume":"57","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Higuchi K, Kobata A et al (2008) Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 57:181\u2013187","journal-title":"Gut"},{"key":"3167_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2015-310861","volume":"65","author":"MA Jackson","year":"2016","unstructured":"Jackson MA, Goodrich JK, Maxan ME et al (2016) Proton pump inhibitors alter the composition of the gut microbiota. Gut 65:749\u2013756","journal-title":"Gut"},{"key":"3167_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vila AV et al (2016) Proton pump inhibitors affect the gut microbiome. Gut 65:740\u2013748","journal-title":"Gut"},{"key":"3167_CR13","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1136\/gutjnl-2016-313312","volume":"66","author":"T Otsuka","year":"2017","unstructured":"Otsuka T, Sugimoto M, Inoue R et al (2017) Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals. Gut 66:1723\u20131725","journal-title":"Gut"},{"key":"3167_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H et al (2015) Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2013a randomised open-label cross-over study. Aliment Pharmacol Ther 42:719\u2013730","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"3167_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/apt.15641","volume":"51","author":"T Takeuchi","year":"2020","unstructured":"Takeuchi T, Furuta T, Fujiwara Y et al (2020) Randomised trial of acid inhibition by vonoprazan 10\/20 mg once daily vs rabeprazole 10\/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study). Aliment Pharmacol Ther 51(5):534\u2013543 (Epub 2020\/01\/29)","journal-title":"Aliment Pharmacol Ther"},{"key":"3167_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","volume":"103","author":"N Yeomans","year":"2008","unstructured":"Yeomans N, Lanas A, Labenz J et al (2008) Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol 103:2465\u20132473","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"3167_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/gutjnl-2017-314852","volume":"67","author":"T Kawai","year":"2018","unstructured":"Kawai T, Oda K, Funao N et al (2018) Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study. Gut 67(6):1033\u20131041 (Epub 2017\/12\/03)","journal-title":"Gut"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jhazmat.2018.05.059","volume":"357","author":"TH Hu","year":"2018","unstructured":"Hu TH, Whang LM, Huang CY (2018) Methanogenic degradation of tetramethylammonium hydroxide by Methanomethylovorans and Methanosarcina. J Hazard Mater 357:180\u2013186","journal-title":"J Hazard Mater"},{"key":"3167_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.12938\/bifidus.25.99","volume":"25","author":"K Nagashima","year":"2006","unstructured":"Nagashima K, Mochizuki J, Hisada T, Suzuki S, Shimomura K (2006) Phylogenetic analysis of 16S ribosomal RNA gene sequences from human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Bioscience and Microflora 25:99\u2013107","journal-title":"Bioscience and Microflora"},{"key":"3167_CR20","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s10557-011-6328-2","volume":"25","author":"H Origasa","year":"2011","unstructured":"Origasa H, Goto S, Shimada K et al (2011) Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study. Cardiovasc Drugs Ther 25:551\u2013560","journal-title":"Cardiovasc Drugs Ther"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12328-012-0300-y","volume":"5","author":"H Hiraishi","year":"2012","unstructured":"Hiraishi H, Oki R, Tsuchida K et al (2012) Frequency of nonsteroidal anti-inflammatory drug-associated ulcers. Clin J Gastroenterol 5:171\u2013176","journal-title":"Clin J Gastroenterol"},{"key":"3167_CR22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00535-013-0839-5","volume":"49","author":"N Uemura","year":"2014","unstructured":"Uemura N, Sugano K, Hiraishi H et al (2014) Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol 49:814\u2013824","journal-title":"J Gastroenterol"},{"issue":"7","key":"3167_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/gutjnl-2013-304722","volume":"63","author":"K Sugano","year":"2014","unstructured":"Sugano K, Choi MG, Lin JT et al (2014) Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study. Gut 63(7):1061\u20131068 (Epub 2013\/12\/12)","journal-title":"Gut"},{"key":"3167_CR24","doi-asserted-by":"crossref","unstructured":"Szabo IL, Matics R, Hegyi P et al (2017) PPIs prevent aspirin-induced gastrointestinal bleeding better than H2RAs. A systematic review and meta-analysis. J Gastrointestin Liver Dis 26:395\u2013402.","DOI":"10.15403\/jgld.2014.1121.264.hra"},{"key":"3167_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1348-0421.2004.tb03526.x","volume":"48","author":"M Kitahara","year":"2004","unstructured":"Kitahara M, Sakata S, Sakamoto M et al (2004) Comparison among fecal secondary bile acid levels, fecal microbiota and Clostridium scindens cell numbers in Japanese. Microbiol Immunol 48:367\u2013375","journal-title":"Microbiol Immunol"},{"issue":"2","key":"3167_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000447690","volume":"94","author":"Y Yamaguchi","year":"2016","unstructured":"Yamaguchi Y, Adachi K, Sugiyama T et al (2016) Association of intestinal microbiota with metabolic markers and dietary habits in patients with type 2 diabetes. Digestion 94(2):66\u201372 (Epub 2016\/10\/19)","journal-title":"Digestion"},{"key":"3167_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/clinids\/11.3.452","volume":"11","author":"LM Baddour","year":"1989","unstructured":"Baddour LM, Christensen GD, Lowrance JH, Simpson WA (1989) Pathogenesis of experimental endocarditis. Rev Infect Dis 11:452\u2013463","journal-title":"Rev Infect Dis"},{"key":"3167_CR28","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2217\/fmb.09.64","volume":"4","author":"K Nakano","year":"2009","unstructured":"Nakano K (2009) Ooshima T\u202f: Serotype classification of Streptococcus mutans and its detection outside the oral cavity. Future Microbiol 4:891\u2013902","journal-title":"Future Microbiol"},{"key":"3167_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/srep00332","volume":"2","author":"A Kojima","year":"2012","unstructured":"Kojima A, Nakano K, Wada K, Takahashi H, Katayama K, Yoneda M, Higarashi T, Nomura R, Hokamura K, Muranaka Y, Matsuhashi N, Umemura K, Kamaisaki Y, Nakajima A (2012) Ooshima T\u202f: Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep 2:332","journal-title":"Sci Rep"},{"key":"3167_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/odi.12125","volume":"20","author":"A Kojima","year":"2014","unstructured":"Kojima A, Nomura R, Naka S, Okawa R, Ooshima T (2014) Nakano K\u202f: Aggravation of inflammatory bowel diseases by oral streptococci. Oral Dis 20:359\u2013366","journal-title":"Oral Dis"},{"issue":"4","key":"3167_CR31","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.gastro.2016.11.023","volume":"152","author":"JR Lam","year":"2017","unstructured":"Lam JR, Schneider JL, Quesenberry CP, Corley DA (2017) Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology 152(4):821-829.e1. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.023","journal-title":"Gastroenterology"},{"key":"3167_CR32","doi-asserted-by":"publisher","first-page":"e0122330","DOI":"10.1371\/journal.pone.0122330","volume":"10","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Takeuchi T, Handa O et al (2015) A multicenter, randomized, double-blind, placebo-controlled trial of high-dose rebamipide treatment for low-dose aspirin-induced moderate-to-severe small intestinal damage. PLoS One 10:e0122330","journal-title":"PLoS ONE"},{"key":"3167_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3164\/jcbn.16-49","volume":"59","author":"K Ota","year":"2016","unstructured":"Ota K, Takeuchi T, Nouda S et al (2016) Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury. J Clin Biochem Nutr 59:231\u2013237","journal-title":"J Clin Biochem Nutr"},{"key":"3167_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1471-230X-13-108","volume":"13","author":"I Watari","year":"2013","unstructured":"Watari I, Oka S, Tanaka S et al (2013) Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenterol 13:108","journal-title":"BMC Gastroenterol"},{"key":"3167_CR35","doi-asserted-by":"crossref","unstructured":"Shiotani A, Haruma K, Nishi R et al (2010) Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 45(3):292\u20138. (Epub 2009\/12\/09)","DOI":"10.3109\/00365520903453182"},{"issue":"46","key":"3167_CR36","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.3748\/wjg.v17.i46.5117","volume":"17","author":"K Mizukami","year":"2011","unstructured":"Mizukami K, Murakami K, Abe T et al (2011) Aspirin-induced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol 17(46):5117\u20135122 (Epub 2011\/12\/16)","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3167_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3164\/jcbn.12-27","volume":"51","author":"K Mizukami","year":"2012","unstructured":"Mizukami K, Murakami K, Hirashita Y et al (2012) Efficacy of rebamipide for low-dose aspirin-related gastrointestinal symptoms. J Clin Biochem Nutr 51(3):216\u2013220. https:\/\/doi.org\/10.3164\/jcbn.12-27","journal-title":"J Clin Biochem Nutr"},{"issue":"8","key":"3167_CR38","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s10620-014-3108-4","volume":"59","author":"K Tozawa","year":"2014","unstructured":"Tozawa K, Oshima T, Okugawa T et al (2014) A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel. Dig Dis Sci 59(8):1885\u20131890 (Epub 2014\/03\/25)","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3167_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3164\/jcbn.09-103","volume":"47","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto T, Isono A, Mishina Y et al (2010) Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. J Clin Biochem Nutr 47(1):27\u201331. https:\/\/doi.org\/10.3164\/jcbn.09-103","journal-title":"J Clin Biochem Nutr"},{"key":"3167_CR40","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00535-011-0410-1","volume":"46","author":"H Endo","year":"2011","unstructured":"Endo H, Higurashi T, Hosono K et al (2011) Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol 46:894\u2013905","journal-title":"J Gastroenterol"},{"key":"3167_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40168-018-0494-4","volume":"6","author":"JA Krumbeck","year":"2018","unstructured":"Krumbeck JA, Rasmussen HE, Hutkins RW et al (2018) Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics. Microbiome 6:121","journal-title":"Microbiome"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03167-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03167-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03167-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T09:13:05Z","timestamp":1635239585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03167-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03167-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]},"assertion":[{"value":"2 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of the Osaka Medical College (approval number: 400), and written informed consent was obtained from all patients. All procedures performed in the study involving human participants were in accordance with the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"KH has received research grants and speaker\u2019s fee from Takeda Chemical Industries, Ltd., and AstraZeneca K.K. The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}